La chaîne d'options affiche les données clés des options sur actions de Greenland Technologies à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Greenland Technologies..

Greenland Technologies (NASDAQ:GTEC) Stock, Chaîne d'Options

Greenland Technologies

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

Greenland Technologies Holding Corporation - Ordinary Shares

Greenland Technologies Holding Corp

Greenland Technologies Holding Corp Warrants - (27/04/2025)

Daqo New Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.69) by 15.94 percent. This is a 245.45 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $123.91 million which missed the analyst consensus estimate of $182.08 million by 31.94 percent. This is a 70.16 percent decrease over sales of $415.31 million the same period last year.

Earnings

Earnings Misses

News

Daqo New Energy Q1 Adj. EPS $(0.80) Misses $(0.69) Estimate, Sales $123.91M Miss $182.08M Estimate

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) raises FY2025 GAAP EPS guidance from $14.20-$14.45 to $14.60-$15.10 vs $14.17 analyst estimate. Lowers FY2025 sales outlook from $14.92 billion-$15.20 billion to $14.78 billion-$15.06 billion vs $14.99 billion estimate.

Guidance

SPGI

S&P Global Raises FY2025 GAAP EPS Guidance from $14.20-$14.45 to $14.60-$15.10 vs $14.17 Est; Lowers FY2025 Sales Guidance from $14.92B-$15.20B to $14.78B-$15.06B vs $14.99B Est

Earnings Beats

NAUT

Nautilus Biotechnology Q1 EPS $(0.13) Beats $(0.16) Estimate, Cash Balance Of $192.8M

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) widens FY2025 Adj EPS guidance from $17.00-$17.25 to $16.75-$17.25 vs $17.01 analyst estimate. Lowers FY2025 sales outlook from $14.92 billion-$15.20 billion to $14.78 billion-$15.06 billion vs $14.99 billion estimate.

S&P Global Widens FY2025 Adj EPS Guidance from $17.00-$17.25 to $16.75-$17.25 vs $17.01 Est; Lowers FY2025 Sales Guidance from $14.92B-$15.20B to $14.78B-$15.06B vs $14.99B Est

As of April 29, 2025, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Pony AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>)</h3>
<ul>
<li>Pony AI chief technology officer Lou Tiancheng told The Wall Street Journal that the company is getting closer to becoming profitable following a series of cost-cutting measures. Following the release of three new robotaxis at the Shanghai Auto Show last week, company executives reportedly said Pony AI can build its most advanced autonomous driving systems for 70% less than before. The company's stock jumped around 143% over the past five days and has a 52-week high of $23.88.</li>
<li>RSI Value: 71.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>PONY Price Action: Shares of Pony AI jumped 47.2% to close at $10.32 on Monday.</li>
<li>Edge Stock Ratings: 91.92 Momentum score with Value at 93.51. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/PONY"><img loading="lazy" decoding="async" width="477" height="186" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29065431/image-208.png" alt="" class="wp-image-892546" style="width:385px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29065431/image-208.png 477w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29065431/image-208-300x117.png 300w" sizes="(max-width: 477px) 100vw, 477px" /></a></figure>
<h3 class="wp-block-heading">Pegasystems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>)</h3>
<ul>
<li>On April 22, Pegasystems reported better-than-expected first-quarter financial results. &#8220;Pega GenAI has dramatically transformed how we engage with our clients,&#8221; said Alan Trefler, Pega founder and CEO. &#8220;Pega solutions and our approach to AI enables clients to accelerate progress in reaching their digital and legacy transformation goals.&#8221; The company's stock gained around 36% over the past five days and<a href="https://www.benzinga.com/quote/PEGA"> has a 52-week high</a> of $113.67.</li>
<li>RSI Value: 70.5</li>
<li>PEGA Price Action: Shares of Pegasystems fell 0.6% to close at $91.11 on Monday.</li>
</ul>
BZ Edge Rankings: Find out where other stocks stand—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">explore the full comparison now</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45060164/general-motors-coca-cola-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

PEGA

PONY

Top 2 Tech Stocks You May Want To Dump This Month

ASTE

Astec Enters Into Definitive Agreement to Acquire TerraSource Holdings For $245M; Anticipates Adj. EBITDA Multiple Of 5.9x Adjusted For Expected Tax Benefits Of ~$15M And Annual Run-Rate Synergies ~$10M By End Of Year Two

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) reported quarterly earnings of $4.37 per share which beat the analyst consensus estimate of $4.19 by 4.3 percent. This is a 8.98 percent increase over earnings of $4.01 per share from the same period last year. The company reported quarterly sales of $3.78 billion which beat the analyst consensus estimate of $3.70 billion by 2.13 percent. This is a 8.19 percent increase over sales of $3.49 billion the same period last year.

S&P Global Q1 Adj. EPS $4.37 Beats $4.19 Estimate, Sales $3.78B Beat $3.70B Estimate

Findings from ALAMO Study Show AlloSure Lung is Associated with Prognosis of Chronic Lung Allograft Dysfunction and Restrictive Allograft Syndrome
AlloSure Lung Surveillance Monitoring Identifies the Onset of Acute Cellular Rejection and Treatment Response
CareDx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) – The Transplant Company&#x2122; – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that CareDx, together with study collaborators, presented new scientific evidence on the use of AlloSure&#xAE; Lung in clinical practice at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting &amp; Scientific Sessions, held from April 27-30 in Boston, Massachusetts.

CDNA

Caredx Presents New Scientific Evidence On Use Of Allosure Lung In Clinical Practice At ISHLT 45Th Annual Meeting & Scientific Sessions

General

Linde To Increase Its Supply Of Industrial Gases To Samsung In South Korea

H&amp;E Equipment Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.63 by 95.24 percent. This is a 95.77 percent decrease over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $319.45 million which missed the analyst consensus estimate of $362.60 million by 11.90 percent. This is a 13.98 percent decrease over sales of $371.36 million the same period last year.

HEES

H&E Equipment Servs Q1 Adj. EPS $0.03 Misses $0.63 Estimate, Sales $319.45M Miss $362.60M Estimate

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the communication services sector.
<h3 class="wp-block-heading">Playtika Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>)</h3>
<ul>
<li>Dividend Yield: 7.65%</li>
<li>Morgan Stanley analyst Matthew Cost maintained an Equal-Weight rating and cut the price target from $7.25 to $5.75 on April 17, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Citigroup analyst Jason Bazinet maintained a Buy rating and lowered the price target from $10 to $9 on March 7, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: Playtika Holding will release financial results for the first quarter before the opening bell on Thursday, May 8.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">PLTK news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429"><img loading="lazy" decoding="async" width="912" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209.png" alt="" class="wp-image-892557" style="width:550px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209-768x709.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">NetEase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>)</h3>
<ul>
<li>Dividend Yield: 2.46%</li>
<li>Barclays analyst Jiong Shao maintained an Equal-Weight rating and raised the price target from $82 to $104 on Feb. 24, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Benchmark analyst Fawne Jiang maintained a Buy rating and raised the price from $105 to $115 on Feb. 21, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On April 15, NetEase announced filing of annual report on Form 20-F for fiscal year 2024.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest NTES <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429"><img loading="lazy" decoding="async" width="903" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210.png" alt="" class="wp-image-892559" style="width:526px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210.png 903w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210-768x723.png 768w" sizes="(max-width: 903px) 100vw, 903px" /></a></figure>
<h3 class="wp-block-heading">AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>)</h3>
<ul>
<li>Dividend Yield: 4.07%</li>
<li>Barclays analyst Kanan Venkateshwar maintained an Overweight rating and raised the price target from $27 to $30 on April 25, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Morgan Stanley analyst Simon Flannery maintained an Overweight rating and raised the price target from $30 to $31 on April 24, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 23, the telecom giant reported quarterly operating revenues of $30.63 billion, up 2.0% year over year. This beat the analyst consensus estimate of $30.35 billion. Adjusted EPS of $0.51 also beat the analyst consensus estimate of $0.49.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">latest T news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429"><img loading="lazy" decoding="async" width="907" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211.png" alt="" class="wp-image-892560" style="width:532px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211-768x690.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45060164/general-motors-coca-cola-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

NTES

PLTK

Wall Street's Most Accurate Analysts Weigh In On 3 Tech And Telcom Stocks Delivering High-Dividend Yields

Correction : Rosenblatt analyst Barton Crockett initiates coverage on Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) with a Buy rating and announces Price Target of $20.(Rating changed)

Initiation

Correction : Rosenblatt Initiates Coverage On Viant Technology with Buy Rating, Announces Price Target of $20 (Rating changed)

On Monday, April 28, U.S. markets closed mixed, with the S&amp;P 500 and Dow posting modest gains while the Nasdaq dipped. Weakness in mega caps like Nvidia and Amazon weighed on sentiment as investors awaited major tech earnings and key economic data. Uncertainty around trade policies and Sino-U.S. negotiations kept markets cautious despite recent stabilization.
In economic data, the Dallas Fed reported that Texas manufacturing activity weakened in April, with its general business activity index falling by 19.5 points to -35.8.
Most S&amp;P 500 sectors advanced Monday, led by real estate, energy, and utilities, while consumer staples and tech lagged.
The Dow Jones Industrial Average was up 0.28% to 40,227.59, the S&amp;P 500 rose 0.06% to 5,528.75, while the Nasdaq declined 0.10% to 17,366.13.
Asia Markets Today
<ul>
<li>Japan's market closed for the Showa Day holiday.</li>
<li>On Tuesday, Australia's S&amp;P/ASX 200 gained 0.92%, ending the session at 8,070.60, led by gains in the Energy, Utilities, and Resources sectors.</li>
<li>India's Nifty 50 was up 0.05% at 24,336.50, and Nifty 500 rose 0.09% to 22,122.25.</li>
<li>China's Shanghai Composite slid 0.05% to 3,286.65, and Shanghai Shenzhen CSI 300 was down 0.17% at 3,775.08.</li>
<li>Hong Kong's Hang Seng closed 0.18% higher at 22,008.11.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 index was up 0.02%.</li>
<li>Germany's DAX index gained 0.79%.</li>
<li>France's CAC 40 slid 0.03%.</li>
<li>U.K.'s FTSE 100 index traded higher by 0.09%.</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 1.24% at $61.28/bbl, and Brent was down 1.28% at $63.96/bbl.</li>
<li>Crude oil prices fell as U.S.-China trade tensions weakened demand expectations. OPEC+ output talks, refinery outages, and rising U.S. stockpiles added further pressure on prices.</li>
<li>Natural Gas fell 0.63% to $3.322.</li>
<li>Gold was trading lower by 0.80% at $3,320.89, Silver was up 0.93% to $33.313, and Copper rose 1.228% to $4.9516.</li>
<li>Gold prices fell as easing U.S. auto tariffs calmed trade fears.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were up 0.22%, S&amp;P 500 futures gained 0.15 %, and Nasdaq 100 futures rose 0.19%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. Dollar Index rose 0.33% to 99.26, USD/JPY was up 0.49% to 142.71, and USD/AUD gained 0.24% to 1.5586.</li>
<li>The U.S. dollar edged higher but remained on track for a sharp monthly loss amid tariff uncertainty and economic slowdown fears, while investors awaited key U.S. data and global trade updates.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed, Gold Dips On Trade Truce Hope  - Global Markets Today While US Slept

ZAPP

Zapp EV Expands Into Ireland With Appointment Of First Authorised Reseller In Dublin

Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) is looking for Q2 Adj EPS of $0.55-$0.59 vs $0.56 analyst estimate. sees sales of $3.850 billion vs $3.82 billion analyst estimate.

Corning Sees Q2 Adj EPS $0.55-$0.59 vs $0.56 Est; Sees Core Sales $3.850B vs $3.82B Est

Rosenblatt analyst Barton Crockett initiates coverage on Magnite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Buy rating and announces Price Target of $18.

MGNI

Rosenblatt Initiates Coverage On Magnite with Buy Rating, Announces Price Target of $18

Outlook
"In the first quarter we saw booking strength from January deteriorate into February and worsen into March," said Marty St. George, JetBlue's president. "We expect softened demand for off-peak travel to continue into the second quarter, where the booking curve is more exposed to macro uncertainty and deteriorating consumer confidence. That said, we are committed to our JetForward plan and are encouraged by the resiliency of premium, international, and loyalty revenues - core components of our long-term strategy."
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Second Quarter and Full Year 2025 Outlook</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Estimated 2Q 2025</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Estimated FY 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Available Seat Miles ("ASMs") Year-Over-Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(3.5%) - (0.5%)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">RASM Year-Over-Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(7.5%) - (3.5%)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CASM Ex-Fuel (1), (2) Year-Over-Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">6.5% - 8.5%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fuel Price per Gallon (3), (4)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.25 - $2.40</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest Expense</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$600 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$400 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$1.3 billion</td>
</tr>
</tbody>
</table>
</figure>

JBLU

JetBlue Expects Q2 2025 Available Seat Miles Year-Over-Year Decline Of (3.5%)-(0.5%)

<a href="https://www.globenewswire.com/Tracker?data=k_AP_7XwuO_5EvdiadgYRFP1KPG3qzFhiqX_4zqt3CDb9xzai6sghaCP31YDkTwxUUtoLxQbVADKnGnRFMYl4ACebhgINwmMpoD72kF-kCs=">Pasithea Therapeutics Corp.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other MAPK pathway driven cancer indications, today announced the Company has completed enrollment and initial dosing of three subjects in Cohort 6 with 30 mg capsules of PAS-004.
The ongoing Phase 1 clinical trial is a multi-center, open-label, dose escalation 3+3 study design to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of PAS-004 in patients with MAPK pathway driven advanced solid tumors with a documented RAS, NF1 or RAF mutation or patients who have failed BRAF/MEK inhibition (<a href="https://www.globenewswire.com/Tracker?data=egYAj5B3mYmpOUcK43ywwcGpLB2F9iZ-eYuWoa7kAJ2DEbDIoZyJn5QkulzNtWo810-AKcngoFR72fmYBaqr563TQG-3O60UH-79X1hJdMLIKaG0LK8wjAx9eDccTjkx">NCT06299839</a>).
 &nbsp;

KTTA

Pasithea Therapeutics Completes Enrollment And Initial Dosing Of Three Subjects In Cohort 6 With 30 Mg Capsules Of PAS-004

Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.51 by 5.88 percent. This is a 42.11 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $3.68 billion which beat the analyst consensus estimate of $3.64 billion by 0.98 percent. This is a 12.92 percent increase over sales of $3.26 billion the same period last year.

Comments

Greenland Technologies

Greenland Technologies (GTEC) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL